Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 91.32%
August 31, 2026 91.32%
July 31, 2026 91.32%
June 30, 2026 91.32%
May 31, 2026 91.32%
April 30, 2026 91.32%
March 31, 2026 91.32%
February 28, 2026 91.32%
January 31, 2026 91.32%
December 31, 2025 91.32%
November 30, 2025 91.32%
October 31, 2025 91.32%
September 30, 2025 91.32%
August 31, 2025 91.32%
July 31, 2025 91.32%
June 30, 2025 91.32%
May 31, 2025 91.32%
April 30, 2025 91.32%
March 31, 2025 91.32%
February 28, 2025 91.32%
January 31, 2025 91.32%
December 31, 2024 91.32%
November 30, 2024 91.32%
October 31, 2024 91.32%
September 30, 2024 90.58%
Date Value
August 31, 2024 88.89%
July 31, 2024 88.36%
June 30, 2024 87.24%
May 31, 2024 87.24%
April 30, 2024 87.24%
March 31, 2024 87.24%
February 29, 2024 87.24%
January 31, 2024 87.24%
December 31, 2023 87.24%
November 30, 2023 87.24%
October 31, 2023 87.24%
September 30, 2023 87.24%
August 31, 2023 87.24%
July 31, 2023 87.24%
June 30, 2023 87.24%
May 31, 2023 87.24%
April 30, 2023 87.24%
March 31, 2023 81.74%
February 28, 2023 80.74%
January 31, 2023 80.74%
December 31, 2022 80.74%
November 30, 2022 80.74%
October 31, 2022 80.74%
September 30, 2022 80.58%
August 31, 2022 76.84%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Nicox SA 96.28%
DBV Technologies SA 98.19%
Cellectis SA 97.08%
Genfit SA 90.85%
Innate Pharma SA 85.56%